Global Sustained Release Ocular Drug Delivery Systems Market Research Report 2021

Publisher Name :
Date: 11-Jan-2021
No. of pages: 116
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Liposome

- Microcapsules/Nanocapsules

- Microspheres/Nanosptheres

- Implants

Segment by Application

- Cataract

- Glaucoma

- Corneal Transplantation

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- pSivida

- Allergan

- Icon Bioscience

- Ocular Therapeutix

- Neurotech Pharmaceuticals

- Santen Pharmaceutical

- Aciont Inc.

- Envisia Therapeutics

- GrayBug

- Innocore Pharmaceuticals

- OHR Pharmaceuticals

- PolyActiva

- TheraKine

Global Sustained Release Ocular Drug Delivery Systems Market Research Report 2021

Table of Contents
1 Sustained Release Ocular Drug Delivery Systems Market Overview
1.1 Product Overview and Scope of Sustained Release Ocular Drug Delivery Systems
1.2 Sustained Release Ocular Drug Delivery Systems Segment by Type
1.2.1 Global Sustained Release Ocular Drug Delivery Systems Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Liposome
1.2.3 Microcapsules/Nanocapsules
1.2.4 Microspheres/Nanosptheres
1.2.5 Implants
1.3 Sustained Release Ocular Drug Delivery Systems Segment by Application
1.3.1 Sustained Release Ocular Drug Delivery Systems Sales Comparison by Application: (2021-2027)
1.3.2 Cataract
1.3.3 Glaucoma
1.3.4 Corneal Transplantation
1.3.5 Others
1.4 Global Sustained Release Ocular Drug Delivery Systems Market Size Estimates and Forecasts
1.4.1 Global Sustained Release Ocular Drug Delivery Systems Revenue 2016-2027
1.4.2 Global Sustained Release Ocular Drug Delivery Systems Sales 2016-2027
1.4.3 Sustained Release Ocular Drug Delivery Systems Market Size by Region: 2016 Versus 2021 Versus 2027
2 Sustained Release Ocular Drug Delivery Systems Market Competition by Manufacturers
2.1 Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Manufacturers (2016-2021)
2.2 Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Sustained Release Ocular Drug Delivery Systems Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Sustained Release Ocular Drug Delivery Systems Manufacturing Sites, Area Served, Product Type
2.5 Sustained Release Ocular Drug Delivery Systems Market Competitive Situation and Trends
2.5.1 Sustained Release Ocular Drug Delivery Systems Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Sustained Release Ocular Drug Delivery Systems Players Market Share by Revenue
2.5.3 Global Sustained Release Ocular Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sustained Release Ocular Drug Delivery Systems Retrospective Market Scenario by Region
3.1 Global Sustained Release Ocular Drug Delivery Systems Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Sustained Release Ocular Drug Delivery Systems Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Country
3.3.1 North America Sustained Release Ocular Drug Delivery Systems Sales by Country
3.3.2 North America Sustained Release Ocular Drug Delivery Systems Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Country
3.4.1 Europe Sustained Release Ocular Drug Delivery Systems Sales by Country
3.4.2 Europe Sustained Release Ocular Drug Delivery Systems Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Region
3.5.1 Asia Pacific Sustained Release Ocular Drug Delivery Systems Sales by Region
3.5.2 Asia Pacific Sustained Release Ocular Drug Delivery Systems Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Country
3.6.1 Latin America Sustained Release Ocular Drug Delivery Systems Sales by Country
3.6.2 Latin America Sustained Release Ocular Drug Delivery Systems Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Market Facts & Figures by Country
3.7.1 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales by Country
3.7.2 Middle East and Africa Sustained Release Ocular Drug Delivery Systems Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Sustained Release Ocular Drug Delivery Systems Historic Market Analysis by Type
4.1 Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2016-2021)
4.2 Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Type (2016-2021)
4.3 Global Sustained Release Ocular Drug Delivery Systems Price by Type (2016-2021)
5 Global Sustained Release Ocular Drug Delivery Systems Historic Market Analysis by Application
5.1 Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2016-2021)
5.2 Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Application (2016-2021)
5.3 Global Sustained Release Ocular Drug Delivery Systems Price by Application (2016-2021)
6 Key Companies Profiled
6.1 pSivida
6.1.1 pSivida Corporation Information
6.1.2 pSivida Description and Business Overview
6.1.3 pSivida Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2016-2021)
6.1.4 pSivida Product Portfolio
6.1.5 pSivida Recent Developments/Updates
6.2 Allergan
6.2.1 Allergan Corporation Information
6.2.2 Allergan Description and Business Overview
6.2.3 Allergan Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Allergan Product Portfolio
6.2.5 Allergan Recent Developments/Updates
6.3 Icon Bioscience
6.3.1 Icon Bioscience Corporation Information
6.3.2 Icon Bioscience Description and Business Overview
6.3.3 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Icon Bioscience Product Portfolio
6.3.5 Icon Bioscience Recent Developments/Updates
6.4 Ocular Therapeutix
6.4.1 Ocular Therapeutix Corporation Information
6.4.2 Ocular Therapeutix Description and Business Overview
6.4.3 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Ocular Therapeutix Product Portfolio
6.4.5 Ocular Therapeutix Recent Developments/Updates
6.5 Neurotech Pharmaceuticals
6.5.1 Neurotech Pharmaceuticals Corporation Information
6.5.2 Neurotech Pharmaceuticals Description and Business Overview
6.5.3 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Neurotech Pharmaceuticals Product Portfolio
6.5.5 Neurotech Pharmaceuticals Recent Developments/Updates
6.6 Santen Pharmaceutical
6.6.1 Santen Pharmaceutical Corporation Information
6.6.2 Santen Pharmaceutical Description and Business Overview
6.6.3 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Santen Pharmaceutical Product Portfolio
6.6.5 Santen Pharmaceutical Recent Developments/Updates
6.7 Aciont Inc.
6.6.1 Aciont Inc. Corporation Information
6.6.2 Aciont Inc. Description and Business Overview
6.6.3 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Aciont Inc. Product Portfolio
6.7.5 Aciont Inc. Recent Developments/Updates
6.8 Envisia Therapeutics
6.8.1 Envisia Therapeutics Corporation Information
6.8.2 Envisia Therapeutics Description and Business Overview
6.8.3 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Envisia Therapeutics Product Portfolio
6.8.5 Envisia Therapeutics Recent Developments/Updates
6.9 GrayBug
6.9.1 GrayBug Corporation Information
6.9.2 GrayBug Description and Business Overview
6.9.3 GrayBug Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2016-2021)
6.9.4 GrayBug Product Portfolio
6.9.5 GrayBug Recent Developments/Updates
6.10 Innocore Pharmaceuticals
6.10.1 Innocore Pharmaceuticals Corporation Information
6.10.2 Innocore Pharmaceuticals Description and Business Overview
6.10.3 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Innocore Pharmaceuticals Product Portfolio
6.10.5 Innocore Pharmaceuticals Recent Developments/Updates
6.11 OHR Pharmaceuticals
6.11.1 OHR Pharmaceuticals Corporation Information
6.11.2 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Description and Business Overview
6.11.3 OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2016-2021)
6.11.4 OHR Pharmaceuticals Product Portfolio
6.11.5 OHR Pharmaceuticals Recent Developments/Updates
6.12 PolyActiva
6.12.1 PolyActiva Corporation Information
6.12.2 PolyActiva Sustained Release Ocular Drug Delivery Systems Description and Business Overview
6.12.3 PolyActiva Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2016-2021)
6.12.4 PolyActiva Product Portfolio
6.12.5 PolyActiva Recent Developments/Updates
6.13 TheraKine
6.13.1 TheraKine Corporation Information
6.13.2 TheraKine Sustained Release Ocular Drug Delivery Systems Description and Business Overview
6.13.3 TheraKine Sustained Release Ocular Drug Delivery Systems Sales, Revenue and Gross Margin (2016-2021)
6.13.4 TheraKine Product Portfolio
6.13.5 TheraKine Recent Developments/Updates
7 Sustained Release Ocular Drug Delivery Systems Manufacturing Cost Analysis
7.1 Sustained Release Ocular Drug Delivery Systems Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Sustained Release Ocular Drug Delivery Systems
7.4 Sustained Release Ocular Drug Delivery Systems Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Sustained Release Ocular Drug Delivery Systems Distributors List
8.3 Sustained Release Ocular Drug Delivery Systems Customers
9 Sustained Release Ocular Drug Delivery Systems Market Dynamics
9.1 Sustained Release Ocular Drug Delivery Systems Industry Trends
9.2 Sustained Release Ocular Drug Delivery Systems Growth Drivers
9.3 Sustained Release Ocular Drug Delivery Systems Market Challenges
9.4 Sustained Release Ocular Drug Delivery Systems Market Restraints
10 Global Market Forecast
10.1 Sustained Release Ocular Drug Delivery Systems Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Sustained Release Ocular Drug Delivery Systems by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Sustained Release Ocular Drug Delivery Systems by Type (2022-2027)
10.2 Sustained Release Ocular Drug Delivery Systems Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Sustained Release Ocular Drug Delivery Systems by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Sustained Release Ocular Drug Delivery Systems by Application (2022-2027)
10.3 Sustained Release Ocular Drug Delivery Systems Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Sustained Release Ocular Drug Delivery Systems by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Sustained Release Ocular Drug Delivery Systems by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) Comparison by Application (2021-2027)
Table 3. Global Sustained Release Ocular Drug Delivery Systems Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Sustained Release Ocular Drug Delivery Systems Covered in This Study
Table 5. Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) of Key Manufacturers (2016-2021)
Table 6. Global Sustained Release Ocular Drug Delivery Systems Sales Share by Manufacturers (2016-2021)
Table 7. Global Sustained Release Ocular Drug Delivery Systems Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Sustained Release Ocular Drug Delivery Systems Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Sustained Release Ocular Drug Delivery Systems Average Price (USD/Pcs) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Sustained Release Ocular Drug Delivery Systems Manufacturing Sites and Area Served
Table 11. Manufacturers Sustained Release Ocular Drug Delivery Systems Product Type
Table 12. Global Sustained Release Ocular Drug Delivery Systems Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Sustained Release Ocular Drug Delivery Systems by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sustained Release Ocular Drug Delivery Systems as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Sustained Release Ocular Drug Delivery Systems Sales by Region (2016-2021) & (K Pcs)
Table 16. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region (2016-2021)
Table 17. Global Sustained Release Ocular Drug Delivery Systems Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Sustained Release Ocular Drug Delivery Systems Sales by Country (2016-2021) & (K Pcs)
Table 19. North America Sustained Release Ocular Drug Delivery Systems Sales Market Share by Country (2016-2021)
Table 20. North America Sustained Release Ocular Drug Delivery Systems Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Country (2016-2021)
Table 22. Europe Sustained Release Ocular Drug Delivery Systems Sales by Country (2016-2021) & (K Pcs)
Table 23. Europe Sustained Release Ocular Drug Delivery Systems Sales Market Share by Country (2016-2021)
Table 24. Europe Sustained Release Ocular Drug Delivery Systems Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Sustained Release Ocular Drug Delivery Systems Sales by Region (2016-2021) & (K Pcs)
Table 27. Asia Pacific Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Sustained Release Ocular Drug Delivery Systems Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region (2016-2021)
Table 30. Latin America Sustained Release Ocular Drug Delivery Systems Sales by Country (2016-2021) & (K Pcs)
Table 31. Latin America Sustained Release Ocular Drug Delivery Systems Sales Market Share by Country (2016-2021)
Table 32. Latin America Sustained Release Ocular Drug Delivery Systems Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales by Country (2016-2021) & (K Pcs)
Table 35. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Country (2016-2021)
Table 38. Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Type (2016-2021)
Table 39. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Type (2016-2021)
Table 40. Global Sustained Release Ocular Drug Delivery Systems Revenue (Million US$) by Type (2016-2021)
Table 41. Global Sustained Release Ocular Drug Delivery Systems Revenue Share by Type (2016-2021)
Table 42. Global Sustained Release Ocular Drug Delivery Systems Price (USD/Pcs) by Type (2016-2021)
Table 43. Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) by Application (2016-2021)
Table 44. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2016-2021)
Table 45. Global Sustained Release Ocular Drug Delivery Systems Revenue (Million US$) by Application (2016-2021)
Table 46. Global Sustained Release Ocular Drug Delivery Systems Revenue Share by Application (2016-2021)
Table 47. Global Sustained Release Ocular Drug Delivery Systems Price (USD/Pcs) by Application (2016-2021)
Table 48. pSivida Corporation Information
Table 49. pSivida Description and Business Overview
Table 50. pSivida Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 51. pSivida Sustained Release Ocular Drug Delivery Systems Product
Table 52. pSivida Recent Developments/Updates
Table 53. Allergan Corporation Information
Table 54. Allergan Description and Business Overview
Table 55. Allergan Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 56. Allergan Sustained Release Ocular Drug Delivery Systems Product
Table 57. Allergan Recent Developments/Updates
Table 58. Icon Bioscience Corporation Information
Table 59. Icon Bioscience Description and Business Overview
Table 60. Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 61. Icon Bioscience Sustained Release Ocular Drug Delivery Systems Product
Table 62. Icon Bioscience Recent Developments/Updates
Table 63. Ocular Therapeutix Corporation Information
Table 64. Ocular Therapeutix Description and Business Overview
Table 65. Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 66. Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Product
Table 67. Ocular Therapeutix Recent Developments/Updates
Table 68. Neurotech Pharmaceuticals Corporation Information
Table 69. Neurotech Pharmaceuticals Description and Business Overview
Table 70. Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 71. Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product
Table 72. Neurotech Pharmaceuticals Recent Developments/Updates
Table 73. Santen Pharmaceutical Corporation Information
Table 74. Santen Pharmaceutical Description and Business Overview
Table 75. Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 76. Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Product
Table 77. Santen Pharmaceutical Recent Developments/Updates
Table 78. Aciont Inc. Corporation Information
Table 79. Aciont Inc. Description and Business Overview
Table 80. Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 81. Aciont Inc. Sustained Release Ocular Drug Delivery Systems Product
Table 82. Aciont Inc. Recent Developments/Updates
Table 83. Envisia Therapeutics Corporation Information
Table 84. Envisia Therapeutics Description and Business Overview
Table 85. Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 86. Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Product
Table 87. Envisia Therapeutics Recent Developments/Updates
Table 88. GrayBug Corporation Information
Table 89. GrayBug Description and Business Overview
Table 90. GrayBug Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 91. GrayBug Sustained Release Ocular Drug Delivery Systems Product
Table 92. GrayBug Recent Developments/Updates
Table 93. Innocore Pharmaceuticals Corporation Information
Table 94. Innocore Pharmaceuticals Description and Business Overview
Table 95. Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 96. Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product
Table 97. Innocore Pharmaceuticals Recent Developments/Updates
Table 98. OHR Pharmaceuticals Corporation Information
Table 99. OHR Pharmaceuticals Description and Business Overview
Table 100. OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 101. OHR Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Product
Table 102. OHR Pharmaceuticals Recent Developments/Updates
Table 103. PolyActiva Corporation Information
Table 104. PolyActiva Description and Business Overview
Table 105. PolyActiva Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 106. PolyActiva Sustained Release Ocular Drug Delivery Systems Product
Table 107. PolyActiva Recent Developments/Updates
Table 108. TheraKine Corporation Information
Table 109. TheraKine Description and Business Overview
Table 110. TheraKine Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 111. TheraKine Sustained Release Ocular Drug Delivery Systems Product
Table 112. TheraKine Recent Developments/Updates
Table 113. Production Base and Market Concentration Rate of Raw Material
Table 114. Key Suppliers of Raw Materials
Table 115. Sustained Release Ocular Drug Delivery Systems Distributors List
Table 116. Sustained Release Ocular Drug Delivery Systems Customers List
Table 117. Sustained Release Ocular Drug Delivery Systems Market Trends
Table 118. Sustained Release Ocular Drug Delivery Systems Growth Drivers
Table 119. Sustained Release Ocular Drug Delivery Systems Market Restraints
Table 120. Global Sustained Release Ocular Drug Delivery Systems Sales Forecast by Type (2022-2027) & (K Pcs)
Table 121. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share Forecast by Type (2022-2027)
Table 122. Global Sustained Release Ocular Drug Delivery Systems Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 123. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share Forecast by Type (2022-2027)
Table 124. Global Sustained Release Ocular Drug Delivery Systems Sales Forecast by Application (2022-2027) & (K Pcs)
Table 125. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share Forecast by Application (2022-2027)
Table 126. Global Sustained Release Ocular Drug Delivery Systems Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 127. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share Forecast by Application (2022-2027)
Table 128. Global Sustained Release Ocular Drug Delivery Systems Sales Forecast by Region (2022-2027) & (K Pcs)
Table 129. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share Forecast by Region (2022-2027)
Table 130. Global Sustained Release Ocular Drug Delivery Systems Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 131. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share Forecast by Region (2022-2027)
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Sustained Release Ocular Drug Delivery Systems
Figure 2. Global Sustained Release Ocular Drug Delivery Systems Market Share by Type in 2020 & 2027
Figure 3. Liposome Product Picture
Figure 4. Microcapsules/Nanocapsules Product Picture
Figure 5. Microspheres/Nanosptheres Product Picture
Figure 6. Implants Product Picture
Figure 7. Global Sustained Release Ocular Drug Delivery Systems Market Share by Application in 2020 & 2027
Figure 8. Cataract
Figure 9. Glaucoma
Figure 10. Corneal Transplantation
Figure 11. Others
Figure 12. Global Sustained Release Ocular Drug Delivery Systems Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Sustained Release Ocular Drug Delivery Systems Market Size 2016-2027 (US$ Million)
Figure 14. Global Sustained Release Ocular Drug Delivery Systems Sales 2016-2027 (K Pcs)
Figure 15. Global Sustained Release Ocular Drug Delivery Systems Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Sustained Release Ocular Drug Delivery Systems Sales Share by Manufacturers in 2020
Figure 17. Global Sustained Release Ocular Drug Delivery Systems Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Sustained Release Ocular Drug Delivery Systems Players: Market Share by Revenue in 2020
Figure 19. Sustained Release Ocular Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region (2016-2021)
Figure 21. Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Region in 2020
Figure 22. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region (2016-2021)
Figure 23. Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region in 2020
Figure 24. U.S. Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. U.A.E Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Sustained Release Ocular Drug Delivery Systems by Type (2016-2021)
Figure 49. Sales Market Share of Sustained Release Ocular Drug Delivery Systems by Application (2016-2021)
Figure 50. Sales Market Share of Sustained Release Ocular Drug Delivery Systems by Application in 2020
Figure 51. Revenue Share of Sustained Release Ocular Drug Delivery Systems by Application (2016-2021)
Figure 52. Revenue Share of Sustained Release Ocular Drug Delivery Systems by Application in 2020
Figure 53. Manufacturing Cost Structure of Sustained Release Ocular Drug Delivery Systems
Figure 54. Manufacturing Process Analysis of Sustained Release Ocular Drug Delivery Systems
Figure 55. Sustained Release Ocular Drug Delivery Systems Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
  • Global Corneal Implants Market Research Report 2021
    Published: 22-Jan-2021        Price: US 2900 Onwards        Pages: 115
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Intracorneal Ring Segments (ICRS) - Keratoprosthesis Segment by Application - Hospitals......
  • Global Eye Drops & Lubricants Market Research Report 2021
    Published: 22-Jan-2021        Price: US 2900 Onwards        Pages: 90
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Antibiotics - Hormone - Artificial Tears - Others Segment by Application - Eye......
  • Global Glaucoma Therapeutics Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
    Published: 21-Jan-2021        Price: US 3500 Onwards        Pages: 107
    Based on the Glaucoma Therapeutics market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in de......
  • Global Conjunctivitis Market Research Report 2021
    Published: 20-Jan-2021        Price: US 2900 Onwards        Pages: 94
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Antibiotic - Pills - Ointment Segment by Application - Newborns - Children......
  • Global Retinoblastoma Treatment Market Size, Status and Forecast 2021-2027
    Published: 19-Jan-2021        Price: US 3900 Onwards        Pages: 96
    Retinoblastoma Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Retinoblastoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment by Type - Congenital (Hereditary) Retinoblastoma......
  • Contact Lens Solution Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
    Published: 18-Jan-2021        Price: US 3000 Onwards        Pages: 94
    Summary Further key aspects of the report indicate that: Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology Chapter 2: Global Industry Summary Chapter 3: Market Dynamics Chapter 4: Global Market Segmentation by region, type and End-Use Chapter 5: North America Market Segmentation by region, type and End-Use Chapter 6: Europe Market Segmentation by region, type and End-Use Chapter 7: Asia-Pacific Market Segmen......
  • Global Eye Drops & Lubricants Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
    Published: 14-Jan-2021        Price: US 3500 Onwards        Pages: 120
    Eye drops are saline ophthalmic preparations, administered through ocular route in the eyes. They may contain steroids, beta receptor blockers, sympathomimetics, prostaglandins, antifungal, antibiotics, topical anaesthetics parasympathomimetics, and non-steroidal anti-inflammatory drugs that depend on their drug category. In addition, some eye drops act as lubricants or tear replacing solutions, which provide soothing sensations to the eyes. Based on the Eye Drops & Lubricants market deve......
  • Global Artificial Tears Market Research Report 2021
    Published: 13-Jan-2021        Price: US 2900 Onwards        Pages: 123
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Artificial Tear Liquid - Artificial Tear Ointment Segment by Application - Dry Eyes Treatmen......
  • Global Latanoprost Market Research Report 2021
    Published: 12-Jan-2021        Price: US 2900 Onwards        Pages: 90
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Brand Drug - Generic Drug Segment by Application - Open-angle Glaucoma - Close-angle ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs